Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | CA12 | O43570 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | CA9 | Q16790 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | PSIP1 | O75475 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9497123 | 0.98 | GAA (0.63) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL10348670 | 0.87 | CA2 (0.59) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL11222680 | 0.85 | GAA (0.52) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL28100405 | 0.85 | GAA (0.66) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL7070254 | 0.84 | CA2 (0.56) | GAAMAPTCA2CA12CA1 | |
| Betanaphthol SCHEMBL11875994 | 0.84 | GAA (0.47) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL11789980 | 0.83 | GAA (0.63) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL10910948 | 0.83 | CA2 (0.63) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL11561407 | 0.82 | GAA (0.57) | GAAMAPTCA2CA12CA1 | |
| SCHEMBL5677264 | 0.81 | CA2 (0.61) | GAAMAPTCA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105566182-B | A kind of 2 amino 4（Ethylsulfonyl）The synthetic method of phenol | 苏州天马精细化学品股份有限公司 | 2018-02-13 | — | — | CN | claimed |
| CN-105566182-A | Synthetic method of 2-amino-4-(ethylsulfonyl) phenol | SUZHOU TIANMA SPECIALTY CHEMICALS CO LTD | 2016-05-11 | — | — | CN | claimed |
| US-20100166765-A1 | BENZOQUINAZOLINE DERIVATIVES | NOVARTIS AG (CH) | 2010-07-01 | — | — | US | claimed |
| EP-1917246-B1 | BENZOQUINAZOLINE DERIVATIVES AND THEIR USE IN TREATING BONE DISORDERS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | claimed |
| EP-1917246-A1 | BENZOQUINAZOLINE DERIVATIVES AND THEIR USE IN TREATING BONE DISORDERS | Novartis AG (CH) | 2008-05-07 | — | — | EP | claimed |
| WO-2007020046-A1 | BENZOQUINAZOLINE DERIVATIVES AND THEIR USE IN TREATING BONE DISORDERS | NOVARTIS AG (CH) | 2007-02-22 | — | — | WO | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-5264139-A | Antioxidant dispersant antiwear VI improver additive and lubricating oil composition containing same | TEXACO INC. (US) | 1993-11-23 | — | — | US | claimed |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | CHECKMATE THERAPEUTICS INC. (KR) | 2026-01-22 | — | — | US | disclosed |
| WO-2023229346-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | 주식회사 체크메이트테라퓨틱스 | 2023-11-30 | — | — | WO | disclosed |
| EP-3369726-B1 | METHOD FOR PRODUCING 2-AMINO-4-SUBSTITUTED PHENOL | SUMITOMO CHEMICAL CO (JP) | 2020-08-26 | — | — | EP | disclosed |
| CN-108349884-B | Process for producing 2-amino-4-substituted phenol | 住友化学株式会社 | 2020-04-21 | — | — | CN | disclosed |
| CN-110437170-A | A kind of synthesis technology according to pearl song rice | UNIV EAST CHINA NORMAL | 2019-11-12 | — | — | CN | disclosed |
| EP-3500245-A1 | COMPOSITION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Summit (Oxford) Limited (GB) | 2019-06-26 | — | — | EP | disclosed |
| US-4017477-A | 3-Halogeno-6-hydroxy-pyridone-(2) azo dyestuffs | CIBA-GEIGY AG (CH) | 1977-04-12 | — | — | US | disclosed |
| US-4005065-A | GOOD FASTNESS TO LIGHT, PERSPIRATION, FULLING, DECATIZING AND CARBONIZING | CIBA-GEIGY CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3993659-A | Bis-benzoxazolyl-naphthalenes as optical brighteners | CIBA-GEIGY CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3985763-A | DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-12 | — | — | US | disclosed |
| US-3971738-A | Heavy metal complexes of azo compounds containing a halogeno-2,3-dihydroxy pyridine coupling component | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
| US-3933785-A | Azo compounds | CIBA-GEIGY AG (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166765-A1 | BENZOQUINAZOLINE DERIVATIVES | CACNA1A, BMP4, TPX2 | GAA 1216/4885MAPT 4506/4885CA2 22/4885 |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | NAMPT, NAPRT, NNT | GAA 2409/4885MAPT 1402/4885CA2 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.